Bartlett & Co. Wealth Management LLC Horizon Therapeutics Public LTD CO Transaction History

Bartlett & Co. Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.0 - $116.3 $0 - $7.66 Million	-65,882 Closed	0 $0
Q3 2023 Feb 14, 2024	SELL	$98.98 - $115.74 $491,237 - $574,417	-4,963 Reduced 7.01%	65,882 $7.62 Billion
Q2 2023 Feb 14, 2024	BUY	$96.34 - $112.38 $6.1 Million - $7.12 Million	63,345 Added 844.6%	70,845 $7.29 Billion
Q4 2022 Feb 14, 2024	SELL	$62.39 - $113.8 $155,975 - $284,500	-2,500 Reduced 25.0%	7,500 $854 Million
Q2 2022 Feb 14, 2024	SELL	$79.4 - $116.36 $110,048 - $161,274	-1,386 Reduced 12.17%	10,000 $798 Million

Q1 2022 Feb 14, 2024	BUY	$86.42 - $109.81 $33,358 - $42,386	386 Added 3.51%	11,386 $1.2 Billion
Q3 2021 Feb 13, 2024	BUY	$91.91 - $110.37 $1.01 Million - $1.21 Million	11,000 New	11,000 $1.2 Billion

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.